Drug companies are continuing to raise prices with no accountability, causing the price of health care to increase for all.
Higher Drug Prices = Higher Premium Costs
Prescription drugs are the second highest expense incurred by California’s health plans, but drug companies continue to raise prices – with no accountability. With bills continuing to be introduced at the Capitol that will do nothing to reign in high cost prescription drugs, prices will continue to increase, directly effecting health care and premium costs for employers, individuals, and families.
In Just One Year
-
Increased prescription drug costs led to a 5.3% increase in health plan premiums between 2018 and 2019.
-
More expensive specialty drugs accounted for just 1.5% of all prescriptions but made up 56.1% of health plan drug spending.
-
Health plan spending on prescription drugs increased by $600 million from 2018 to 2019.
Stay Informed
Stay up to date on the fight against runaway prescription drug prices.
Co-pays and deductible caps don’t address the biggest problem with the drug market: extremely inflated prices set by #BigPharma.
#TheProblemIsThePrice https://t.co/QT2pXR28G4
ICYMI: The annual New Year’s mass price hike from #BigPharma raised prices on 460 drugs across sectors, including HIV and breast cancer treatments.
Read more about how these drug hikes impact healthcare affordability, from @bobjherman in @Axios
https://t.co/LXvSBcZbFK
ICYMI: During the biggest overdose crisis in modern American history, nonprofits are struggling to afford Narcan, the most essential treatment for overdoses, due to #BigPharma price hikes.
#TheProblemIsThePrice
https://t.co/vvxDknNCGc
In 2020, health plans covered 92.8% of the most expensive drugs across brand name, generic, and specialty drugs.
https://t.co/92IqAKMbnL
